In October 2018, the Canaud Lab received a donation from the CLOVES Syndrome Community. This donation will be used for the creation of animal models to test PIK3CA inhibitors. Learn more about the CLOVES Syndrome...
In 2018, Guillaume Canaud received a grant from the Simone and Cino Del Duca Foundation. Three annual grants are intended for young French teams leading research projects in annually defined fields (chemistry, cellular and molecular biology, genomics, integrative...
On March 5, 2018, Guillaume Canaud received the Institut Necker Prize during the annual ceremony of the Tourre Foundation, held at the Paris Descartes University, in the presence of a large audience. Since 2011, the Tourre Foundation has allocated a total of € 395,000...
Congratulation to Quitterie for her work on PIK3CA inhibition in patients with PIKC3CA Related Overgrowth Syndrome published in Nature! The team recently demonstrated the efficacy of a novel medication, a specific inhibitor called BYL719, in a cohort of 19 patients...
Guillaume Canaud obtained a 2016 ERC Proof of Concept Grant entitled: CureTheCloves. Briefly, the Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, Scoliosis/Skeletal and Spinal (CLOVES) syndrome is a genetic disorder due to a gain of function...
Congratulation to Marianne for her work on B7-1 blockade and post transplant nephrotic syndrome published in J Am Soc Nephrol! B7–1 Blockade Does Not Improve Post–Transplant Nephrotic Syndrome Caused by Recurrent FSGS Abstract FSGS is a common glomerular disorder that...
